Hikma, GB00B128J450

Hikma stock ahead of the Xetra open with prior close of EUR 0.85 on September 29, 2026

Published on 09/30/2026 at 08:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hikma stock is ahead of the Xetra open with a Lang & Schwarz prior close of EUR 0.85 on September 29, 2026. The company has named Rebecca Hall as its next CFO.

Fotorealistische sterile Pharma-Produktionslinie mit Injektionsfläschchen und Edelstahlanlagen
Hikma Pharmaceuticals PLC GB00B128J450 zeigt moderne Injektions-Produktionslinie in sterilem Pharmawerk mit Edelstahlanlagen, Illustration mit AI erstellt.

Hikma stock is ahead of the Xetra open with the prior close at Lang & Schwarz at EUR 0.85 on September 29, 2026. No daily percentage change is stated.

Leadership appointment

Hikma announced on September 24, 2026, that Rebecca Hall will become group chief financial officer and executive director. Hall is expected to join in the first quarter of 2027, with Hikma to confirm the appointment date. She will replace Khalid Nabilsi on the board, who is scheduled to step down on December 31, 2026, while continuing as deputy CEO for North America and Europe.

R&D investor series

In a September 22, 2026 release, Hikma announced three educational investor seminars on its research and development strategy. The sessions are scheduled for October 20, November 24 and December 16, 2026. Hikma said it aspires to spend around 5% to 6% of revenue on R&D going forward and noted that the seminars will not provide new material financial or trading information.

Disclaimer...

en | GB00B128J450 | HIKMA | boerse | 70202508 | bgmi